P61 Health State Utility Values and Quality of Life in Patients Receiving Ripretinib in the Phase 3 Invictus Trial and a Real-World Evidence Study in China
| Autor: | Jones, RL, Blay, JY, Chi, P, Bauer, S, Gelderblom, H, Shen, L, He, YL, Heinrich, MC, Schöffski, P, Zalcberg, JR, Harrow, B, Sherman, ML, Ruiz-Soto, R, Becker, C, von Mehren, M |
|---|---|
| Zdroj: | In Value in Health December 2022 25(12) Supplement:S14-S15 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect